Impact of pantoprazole on absorption and disposition of hydroxychloroquine, a drug used in Corona Virus Disease-19 (Covid-19): A structured summary of a study protocol for a randomised controlled trial
Abstract Objectives Primary objective: Evaluation of the effect of the proton pump inhibitor (PPI) pantoprazole on the absorption of hydroxychloroquine (HCQ). Secondary objectives: • Evaluation of the relationship between HCQ concentrations in whole blood, plasma and intracellular concentrations in...
Main Authors: | Felicitas Stoll, Antje Blank, Gerd Mikus, David Czock, Kathrin I. Foerster, Simon Hermann, Katja Häußler, Amin Muhareb, Simone Hummler, Johanna Weiss, Jürgen Burhenne, Walter E. Haefeli |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2020-06-01
|
Series: | Trials |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13063-020-04476-y |
Similar Items
-
Hydroxychloroquine as Prophylaxis for COVID-19: A Review
by: Manuela Monti, et al.
Published: (2020-12-01) -
Short-term, high-dose hydroxychloroquine corneal toxicity
by: Daniel E. Savage, et al.
Published: (2020-06-01) -
Pharmacokinetics of Pantoprazole and Pantoprazole Sulfone in Goats After Intravenous Administration: A Preliminary Report
by: Joe S. Smith, et al.
Published: (2021-09-01) -
Efficacy and safety of a fixed-dose combination of nimesulide/pantoprazole compared to naproxen/esomeprazole for pain relief in patients with osteoarticular diseases and dyspeptic symptoms
by: Scheinberg M, et al.
Published: (2018-09-01) -
Will Hydroxychloroquine Still Be a Game-Changer for COVID-19 by Combining Azithromycin?
by: Chunfeng Li, et al.
Published: (2020-08-01)